Pharmaron Beijing Co Ltd (300759) - Total Liabilities

Latest as of September 2025: CN¥10.62 Billion CNY ≈ $1.55 Billion USD

Based on the latest financial reports, Pharmaron Beijing Co Ltd (300759) has total liabilities worth CN¥10.62 Billion CNY (≈ $1.55 Billion USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore 300759 net asset momentum to track the company's year-over-year net asset growth rate.

Pharmaron Beijing Co Ltd - Total Liabilities Trend (2014–2024)

This chart illustrates how Pharmaron Beijing Co Ltd's total liabilities have evolved over time, based on quarterly financial data. See Pharmaron Beijing Co Ltd free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.

Pharmaron Beijing Co Ltd Competitors by Total Liabilities

The table below lists competitors of Pharmaron Beijing Co Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Corporacion Acciona Energias Renovables SA MC:ANE	Spain	€8.54 Billion
Tetra Tech Inc NASDAQ:TTEK	USA	$2.50 Billion
The Magnum Ice Cream Company N.V. AS:MICC	Netherlands	€6.86 Billion
ASM Pacific Technology Limited F:AY7A	Germany	€8.98 Billion
Turkiye Is Bankasi AS Class C IS:ISCTR	Turkey	TL4.88 Trillion
Ternium S.A F:T5Z	Germany	€7.74 Billion
Oil India Limited NSE:OIL	India	Rs552.76 Billion
AptarGroup Inc NYSE:ATR	USA	$2.42 Billion

Liability Composition Analysis (2014–2024)

This chart breaks down Pharmaron Beijing Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Pharmaron Beijing Co Ltd market cap and net worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.50	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.73	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.41	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Pharmaron Beijing Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Pharmaron Beijing Co Ltd (2014–2024)

The table below shows the annual total liabilities of Pharmaron Beijing Co Ltd from 2014 to 2024.

Year	Total Liabilities	Change
2024-12-31	CN¥9.70 Billion ≈ $1.42 Billion	-26.70%
2023-12-31	CN¥13.24 Billion ≈ $1.94 Billion	+37.15%
2022-12-31	CN¥9.65 Billion ≈ $1.41 Billion	+19.26%
2021-12-31	CN¥8.09 Billion ≈ $1.18 Billion	+172.06%
2020-12-31	CN¥2.98 Billion ≈ $435.34 Million	+41.87%
2019-12-31	CN¥2.10 Billion ≈ $306.86 Million	-8.17%
2018-12-31	CN¥2.28 Billion ≈ $334.16 Million	+19.63%
2017-12-31	CN¥1.91 Billion ≈ $279.33 Million	+83.35%
2016-12-31	CN¥1.04 Billion ≈ $152.35 Million	+3.48%
2015-12-31	CN¥1.01 Billion ≈ $147.23 Million	+49.45%
2014-12-31	CN¥673.22 Million ≈ $98.51 Million	--

About Pharmaron Beijing Co Ltd

SHE:300759 China Biotechnology

Market Cap

$7.67 Billion

CN¥52.39 Billion CNY

Market Cap Rank

#2678 Global

#314 in China

Share Price

CN¥35.48

Change (1 day)

-8.08%

52-Week Range

CN¥21.72 - CN¥40.30

All Time High

CN¥10080.27